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Abstract
Plasmacytoid dendritic cells (pDC) are a specialized sensor of viral and bacterial nucleic acids and a major producer of IFN-a
that promotes host defense by priming both innate and acquired immune responses. Although synthetic Toll-like receptor
(TLR) ligands, pathogenic bacteria and viruses activate pDC, there is limited investigation of non-pathogenic microbiota that
are in wide industrial dietary use, such as lactic acid bacteria (LAB). In this study, we screened for LAB strains, which induce
pDC activation and IFN-a production using murine bone marrow (BM)-derived Flt-3L induced dendritic cell culture.
Microbial strains with such activity on pDC were absent in a diversity of bacillary strains, but were observed in certain
spherical species (Lactococcus, Leuconostoc, Streptococcus and Pediococcus), which was correlated with their capacity for
uptake by pDC. Detailed study of Lactococcus lactis subsp. lactis JCM5805 and JCM20101 revealed that the major type I and
type III interferons were induced (IFN-a,- b, and l). IFN-a induction was TLR9 and MyD88-dependent; a slight impairment
was also observed in TLR4
-/- cells. While these responses occurred with purified pDC, IFN-a production was synergistic upon
co-culture with myeloid dendritic cells (mDC), an interaction that required direct mDC-pDC contact. L. lactis strains also
stimulated expression of immunoregulatory receptors on pDC (ICOS-L and PD-L1), and accordingly augmented pDC
induction of CD4
+CD25
+FoxP3
+ Treg compared to the Lactobacillus strain. Oral administration of L. lactis JCM5805 induced
significant activation of pDC resident in the intestinal draining mesenteric lymph nodes, but not in a remote lymphoid site
(spleen). Taken together, certain non-pathogenic spherical LAB in wide dietary use has potent and diverse
immunomodulatory effects on pDC potentially relevant to anti-viral immunity and chronic inflammatory disease.
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Introduction
Dendritic cells (DC) are a crucial immune cell subset linking
innate immune response and acquired immunity, by their distinct
capacity to recognize pathogenic and endogenous inflammatory
signals. DC are comprised of numerous populations that vary in
their tissue distribution, pattern of cytokines/chemokine produc-
tion, and their interactions with other immune cells. However, at
the simplest level they DC are subdivided into plasmacytoid
dendritic cell (pDC), myeloid dendritic cell (mDC) and CD8
+
dendritic cell (CD8
+DC). pDC is a rare subset representing less
than 1% of murine spleen and lymph node cells [1] and human
peripheral blood mononuclear cells [2]. They are notable for their
distinct use of certain toll-like receptor (TLR) families that sense
the presence of bacteria and viruses. In particular, TLR9, which
recognizes microbial nucleic acids by detecting unmethylated CpG
motifs of DNA, and TLR7, that sense microbial RNA or synthetic
guanosine analogs [3], are endosomal receptors that are highly
expressed in pDC, and lead to their production of type I
interferons (IFN).
The type I IFN family includes IFN-a and IFN-b which serve as
a first-line defense in infection and prime both innate and adaptive
immune responses [4–6]. Other IFNs, such as IFN-b, IFN-c and
IFN-l are also important for anti-viral immunity [7,8] notably as
products of macrophages and TNF or iNOS producing DC [9],
monocyte-derived DC [10] and pDC in response to viruses and
TLRLs in humans [11] and mice [12]. Type I IFN blocks viral
replication by inducing a series of proteins such as MxA, an IFNa-
inducible intracellular protein [13], oligoadenylate synthetase, and
double-stranded RNA-(dsRNA-)-dependent protein kinase (PKR).
Accordingly, they have formed the basis for biologic therapy in a
number of viral infectious diseases [14]. Furthermore, type I IFN
also trigger differentiation and maturation of mDC [15],
modulation of CD8
+T cells [16], activation of Th1 [17], NK cells
[18], and induction of primary response of antibodies [19,20].
Thus, agonistic agents of pDC or type I IFN itself are anticipated
to be therapeutically useful in cancer and allergy therapy.
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infection, several taxa of pathogenic bacteria, such as Chlamydia
[21], Salmonella [22], Mycobacteria [23,24], Listeria [25], and
Staphylococcus aureus [26] elicit IFN-a production in humans and
mice, the latter mediated by pDC [27]. Nonpathogenic microbiota
have been less studied regarding DC-mediated IFN induction. A
category of such microbiota of interest are lactic acid bacteria
(LAB), used in commercial probiotic preparations, and consumed
in variety of foods, such as yogurt, dietary supplement, pickles,
alcohol beverages, and soft drinks. One of their well-documented
impacts on immunity of LAB is an ability to skew an allergic Th2
response toward a Th1 phenotype via eliciting IL-12 production
from macrophages and mDC [28–32]. Previously, we have
reported that IL-12 inductive activity of LAB is highly diverse
depending on species and strain [32]. LAB strains with the most
potent inducing activity for IL-12 appear to prevent allergic
symptoms, based both on mouse models [33] and a human clinical
trial [34]. An additional intriguing function of LAB is induction of
the anti-inflammatory cytokine, IL-10. Allergic symptoms are
ameliorated or prevented by consumption of specific LAB strain in
humans via induction of IL-10 [35–37].
The cell types involved in these immunologic responses to
LAB are incompletely understood, and studies thus far have
focused on macrophages and mDC. pDC, notable for their
production of type I IFNs, may have an unappreciated role in
these LAB-host interactions. In the present study, we identify a
subset of non-pathogenic LAB highly inducing for IFN-a, IFN-b
and IFN-l. We also provide evidence for their pDC-dependent
induction of Treg, and a surprising cross-talk of mDC in these
LAB-induced pDC roles. Furthermore, oral intake of one of the
selected strains of L. lactis JCM5805 significantly increased pDC
activation markers in mesenteric lymph node (MLN), a direct
draining site for dietary LAB and their products. These data
provide new insights into the immunologic profile of the host
response to LAB strains, which may be pertinent to their utility
as a host modifier in viral infection and cancer.
Materials and Methods
Mice
Eight to ten weeks old female C57BL/6J wild-type, TLR2
-/-,
TLR4
-/-, TLR7
-/-, TLR9
-/- and MyD88
-/- were purchased from
Charles River Japan.
BM-derived DC Culture
Flt-3L induced DC were generated as previously described [38].
In short, BM cells were extracted from C57BL/6J, and
erythrocytes were removed by brief exposure to 0.168 M NH4Cl.
Cells were cultured at a density of 5610
5 cells/ml for 7 days in
RPMI1640 medium supplemented with 1 mM sodium pyruvate
(Invitrogen), 2.5 mM HEPES (Invitrogen), penicillin-streptomycin
(Invitrogen), 50 mM 2-ME (Invitrogen), 10% FCS and 100 ng/ml
Flt-3L (R&D systems). LAB were added at the concentrations of
10 mg/ml, and cultures were continued for 48 hrs. 1 mg/ml of
Pam3CSK4 (invivogen), 10 mg/ml ofPoly(I:C) (invivogen), 5 ng/ml
of LPS (Sigma), 0.1 mM of CpG-A (invivogen) and 10 mg/ml of
lipoteicoic acid (invivogen) were used as positive controls.
LAB Strains
LAB strains tested in this study were purchased from the
collections held at Japan Collection of Microorganisms (JCM),
Institute for Fermentation Osaka (IFO), Tokyo University of
Agriculture Culture Collection Center (NRIC), American Type
Culture Collection (ATCC), NITE Biological Resource Center
(NBRC) and DANISCO. Cultures of LAB strains were grown at
30
oCo r3 7
oC for 48 hrs in MRS broth (OXOID) or GAM broth
(Nissui) or M17 broth (OXOID) according to instructions.
Cultured LAB strains were washed twice with sterile distilled
water, heat-killed at 100
oC, lyophilized and suspended in PBS.
Live organisms were also tested. Live or heat-killed LAB cell
numbers were calculated by using a particle counter (CDA-
1000X, Sysmex).
Antibodies
The following fluorescence-conjugated anti-mouse mAbs were
purchased from eBioscience: B220 (RA3-6B2), CD11c (N418),
MHC Class II (M5/114.15.2), CD40 (HM40-3), CD80-APC (16–
10A1), CD86 (GL1), PD-L1 (M1H5), ICOS-L (HK5.3), CD25
(PC61.5), FoxP3 (FJK-16s), CD4 (L3T4) and IFN-c (XMG1.2).
CD3e (145-2C11) and CD11b (M1/70) were from BD Pharmin-
gen. Anti-mPDCA-1 (JF05-1C2.4.1) was purchased from Miltenyi
Biotec.
FACS Analysis
Cells for FACS analysis were stained with fluorescent dye-
conjugated Abs (FITC, PE, PerCP, APC, PE-Cy7, APC-Cy7).
After staining, the cells were washed twice with FACS buffer (0.5%
BSA in PBS buffer) and suspended in 2% paraformaldehyde for
FACS analysis. Data were collected by FACS Cant II (BD
Biosciences) and analyzed by FCS Express software (De Novo
Software) for % positive cells and expression levels of gated cells.
BM-derived Flt-3L induced pDC and mDC was defined as
CD11c
+CD11b
-B220
+ and CD11c
+CD11b
+B220
-, respectively.
Purification of pDC and mDC
pDC and mDC from BM-derived Flt-3L induced DC culture
were sorted by FACS Aria (BD Biosciences). Purity of sorted pDC
or mDC was more than 95%.
Isolation and Purification of DNA from LAB Strains
Total DNA was prepared as described previously [39].
ELISA
Mouse Interferon Alpha ELISA Kit and Mouse Interferon beta
ELISA Kit were purchased from PBL Biomedical Laboratories.
Mouse IFN-c Ready-SET-GO, Mouse TNF-a Ready-SET-GO
and Mouse IL-28/IFN-l Ready-SET-GO kit were purchased
from eBiosciences. Mouse IL-12 (p40) ELISA set was purchased
from BD Pharmingen.
Transwell Culture Assay
Purified pDC and mDC were cultured using Transwell filter
(0.4 mm in pore diameter; Costar) at a density of 1610
5 cells/ml in
various conditions as below. (1) Purified pDC were seeded in
conditioned medium (denoted pDC). (2) Purified mDC were
seeded in conditioned medium (indicated as mDC). (3) 1610
5
cells/ml of purified pDC and mDC were mixed at the ratio of 1:1
in conditioned medium (denoted pDC+mDC). (4) Purified pDC
and mDC were seeded in the upper chamber (inserts) and the
bottom chamber, respectively (denoted pDC/mDC). (5) Purified
mDC and pDC were seeded in the upper chamber and the bottom
chamber, respectively (denoted mDC/pDC), and CpG-A or LAB
(0.1 mM and 10 mg/ml, respectively) were added to the upper
chamber or medium and cultured for 48 hrs at 37
oC. Culture
supernatants were assayed for concentrations of IFN-a, IL-12 and
TNF-a.
Spherical Lab Activate Plasmacytoid Dendritic Cells
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e32588Microscopic Observation of Activation of DC and
Incorporation of LAB Into DC
To observe morphology of pDC stimulated by LAB, sorted
pDC were stimulated with LAB for 48 hrs, attached to glass slides
(Matsunami glass Ind., Ltd) using Cytospin (Thermo Scientific),
and stained by Diff-Quick (Sysmex) according to the manufactur-
er’s protocol.
To assess uptake of LAB, fluorescent LAB were produced by
suspending LAB at 1 mg/ml in a FITC solution (FITC isomer 1
(Sigma) dissolved in 0.1M NaHCO3 pH9.0 buffer at 0.1 mg/ml),
and incubated for 60 min at 25
oC. LAB were washed three times
with PBS and yielded FITC-labeled LAB. BM-derived purified
pDC were placed onto glass coverslips (Matsunami Glass
Industries, Ltd.). FITC-labeled LAB (10 mg/ml) were added to
coverslips bearing pDC and incubated for 24 hrs at 37
oC.
Subsequently, the coverslips were washed with PBS and stained
with anti-B220- PE-Cy5.5 (e Bioscience) for 1 hr. Fluorescent
microscopic observation was performed using a OLYMPUS
BX60.
Mixed Lymphocyte Reaction
Splenic naı ¨ve CD4
+T cell were prepared from BALB/c with
CD4
+CD62L
+ T cell isolation kit II (Miltenyi Biotec) according to
manufacturer’s instructions. DCs were induced from C57BL/6
BM cells and pDC were sorted with a FACS Aria. Purified pDC
were stimulated with 10 mg/ml of L. lactis JCM5805 or L. rhamnosus
ATCC53103 or 0.1 mM of CpG-A overnight. Then, pDC were
treated with 10 mg/ml of mitomycin C (Dojindo) for 30 min at
37
oC and co-cultured with 5610
5 cells/ml of BALB/c naı ¨ve
CD4
+T cell in RPMI medium supplemented with or without
0.75 ng/ml of human TGF-b (Peprotech) for 7 days. Cells
cultured in the presence of TGF-b were collected and washed with
PBS, then stained for CD3, CD4 and CD25. Next, cells were
treated using FoxP3 staining buffer set (eBioscience) according to
manufacturer’s instructions and were stained for intracellular
FoxP3. Cells were gated on CD3
+CD4
+, and then evaluated for
CD25 and FoxP3 expression. Cells cultured in the absence of
TGF-b were stained for CD3, CD4, then fixed by Cytofix/
Cytoperm kit (BD biosciences) according to manufacturer’s
instructions, and finally stained for intracellular IFN-c.
In Vivo Response to L. Lactis JCM5805
6 weeks-old female C57BL/6 mice were acclimatized for 1 week
with free access to water and a basic diet, AIN93G (Oriental
Yeast, Tokyo, Japan). Mice were divided into two groups, each
group consisting of eight mice. Control groups were fed AIN93G,
and test groups were fed AIN93G to achieve 1 mg/ mouse/day of
L. lactis JCM5805. Two weeks later, mice were sacrificed, and
spleen and MLN were excised. To analyze DCs status, low density
cells fractions were prepared as described previously with some
modifications [38]. Spleen and MLN were minced in Mg
2+- and
Ca
2+-free HBSS and digested with 1 mg/ml collagenase (Sigma)
and 0.2 mg/ml DNase I for 30 min at 37
oC. EDTA was adjusted
to 30 mM and incubated for 10 min at room temperature. Tissue
lysates were filtered through a 100 mm nylon cell strainer and
layered onto 15% Histodenz (Sigma) in RPMI1640 containing
10% FCS, and centrifuged at 4506g for 20 min without braking.
Low-density cells at the interface were collected, stained for
CD11c, CD11b, mPDCA-1, CD86 and MHC class II), and
analyzed for CD86 and MHC class II expression on pDC and
mDC by FACS Canto II. pDC and mDC were defined as
CD11c
+CD11b
-mPDCA-1
+ and CD11c
+CD11b
+mPDCA-1
-, re-
spectively. Animal procedures and experiments were approved by
Laboratory Animal Care Committee of Central Laboratories for
Frontier Technology, Kirin Holdings Co., Ltd. The approval ID
of experiments is YO1000035.
Statistics
Results were evaluated by standard student’s t test.
Results
Screening of LAB Strains which Induce IFN-a Production
from BM-derived DC
We first screened for LAB species and strains that with the
capacity to stimulate DC. As listed in Table S1 (rod-shaped strains)
and Table S2 (spherical strains), 125 LAB strains representing 31
species were tested using BM-derived Flt-3L induced DC cultures.
BM-derived Flt-3L culture yields a mixture of pDC
(CD11c
+CD11b
-B220
+) and mDC (CD11c
+CD11b
+B220
-).
10 mg/ml of heat-killed LAB strains were added to Flt-3L
induced DC culture and IFN-a concentrations were determined
from culture supernatants. Significant IFN-a production
(.50 pg/ml) was induced by only a minority of LAB strains:
none of 90 rod-shaped LAB, and only 13 strains of 35 spherical
strains (Table 1). These 13 strains included members of the
Lactococus, Leuconostoc, Streptococcus, and Pediococcus genera. The
most potent stimulators, Lactococcus lactis subsp. lactis JCM5805
and JCM20101, were selected for more detailed study.
Effect of L. Lactis JCM5805 and JCM20101 on mDC and
pDC Activation
In order to detail the effects of selected LAB strains on DC
activation, we evaluated BM-derived Flt-3L induced DC cultures,
gated on pDC and mDC subsets, for changes in cell surface
markers,and production of IFNs. DC cells were cultured with two
representative spherical strains, L. lactis JCM5805 and JCM20101,
a representative rod-shaped strain Lactobacillus rhamnosus
ATCC53103, or the positive control CpG-ODN (Figure 1). We
first compared cell surface marker expression on DC, gated at the
time of analysis for pDC or mDC. In the pDC population,
significant increases (compared to medium control) were induced
by the L. lactis and L. rhamnosus strains for MHC class II and CD80
Table 1. List of strains with significant production of IFN-a.
Strain ID Genera
Production of
IFN-a (pg/ml)
JCM 20101 Lactococcus lactis subsp.lactis 212.53
JCM 5805 Lactococcus lactis subsp.lactis 187.62
NRIC 1150 Lactococcus lactis subsp.lactis 113.00
JCM 1180 Lactococcus lactis subsp.hordniae 95.03
NBRC 100934 Lactococcus garvieae 94.09
NBRC 12007 Lactococcus lactis subsp.lactis 86.87
NBRC 12455 Leuconostoc lactis 86.67
NRIC 1540 Leuconostoc lactis 75.32
TA-45 Streptococcus thermophilus 74.55
JCM 11040 Lactococcus lactis subsp.hordniae 64.42
NBRC 100676 Lactococcus lactis subsp.cremoris 62.41
JCM 5886 Pediococcus damnosus 58.31
JCM 16167 Lactococcus lactis subsp.cremoris 50.35
doi:10.1371/journal.pone.0032588.t001
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CD86, L. rhamnosus had no significant effect on CD40 and CD86
compared to medium control, and there were significant difference
between L. lactis and L. rhamnosus with impact on the co-
stimulatory molecules CD40, CD80 and CD86. Further differ-
enced between L. lactis and L. rhamnosus were observed for cell
surface molecules involved in immune suppression. ICOS-L and
PD-L1, which are reported to induce Treg [40,41]. These were
greatly up-regulated by L. lactis. In contrast, L. rhamnosus had only a
minor effect on PD-L1 and no effect on ICOS-L. Similar results
were observed for mDC, with the interesting exception that ICOS-
L was constitutively elevated in mDC; this expression was reduced
by treatment with both L. lactis and L rhamnosus (Figure 1B).
We next evaluated the effect of L. lactis and L rhamnosus
treatment on DC production of IFNs (IFN-b, IFN-c and IFN-l).
As shown in Figure 2A, both IFN-b and IFN-l1 were induced by
two L. lactis strains, but this was not observed with L. rhamnosus.
Unlike IFN-a, positive control CpG ODN could induce neither
IFN-b nor IFN-l1 at the concentrations tested. The type 2
interferon IFN-c was significantly induced by L. rhamnosus, but this
was not observed with L. lactis strains. The results with IFN-a,
IFN-b and IFN-l were selectively up-regulated by L. lactis strains.
This is consistent with the previous observation that type I and
type III IFNs are typically coordinately regulated [42]. It thus
appears that these L.lactis strains are potent inducers of DC
activation with respect to type I and III IFNs. To confirm whether
activity of LAB strains differed between live and heat-killed cells,
the same numbers of live or heat-killed L.lactis JCM5805 were
tested for stimulation of IFN-a production. As shown in Figure 2B,
there was no statistical difference in IFN-a stimulation by live and
heat-killed JCM5805.
Cooperation between pDC and mDC Involved in IFN-a
Production Induced by L. Lactis
Since Flt-3L induced DC represent a mixed culture of pDC and
mDC, we wondered whether L. lactis JCM5805 and JCM20101
stimulated pDC directly or in association with mDC. To address
this point, IFN-a production was examined using purified pDC,
purified mDC, or mixed pDC/mDC cultures (Figure 3A). L. lactis
strains induced weak IFN-a production from purified pDC, and
no production was observed with L. rhamnosus. Interestingly, the
amount of IFN-a was dramatically increased when pDC was
cultured in the presence of same number of mDC. These data
imply that L. lactis strains stimulated pDC directly, although
maximum effects occurred when mDC and pDC mutually
interacted. In contrast, production of IL-12p40 and TNF-a,
common cytokines produced by mDC, were completely depen-
dent on the presence of mDC, and synergistic effects with pDC
were not detected.
To explore the mechanism of augmented production of IFN-a
elicitedbyL.lactiswhenpDCandmDCwereco-cultured,pDCand
mDCwereseparatelyculturedusingatranswellsystem.WhenpDC
and mDC were separated in the upper and lower chambers, and
LAB strains were added to the upper chamber (pDC/mDC or
mDC/pDC), the synergistic effect on IFN-a production was
completely abrogated (Figure 3B). Therefore, cell-cell contact
between pDC and mDC was required for the synergistic effect on
L. lactis-induced IFN-a production. In contrast, while CpG-ODN
also induced the highest IFN-a production when pDC and mDC
were cultured together, significant production occurred when pDC
and mDC were separated. This data suggests that LAB and CpG-
ODN induced IFN-a production were distinguishable in cellular
interaction requirements.
Figure 1. Comparison of DC activation by L. lactis and L. rhamnosus. Flt-3L induced BM-derived DC were treated with 10 mg/ml of stimulatory
(L. lactis JCM5805 or JCM20101) or non-stimulatory (L. rhamnosus ATCC53103) LAB strains; 0.1 mM of CpG-A was included as a positive control. After
48 hrs, cells were evaluated for expression level of cell-surface markers by flow cytometry. A. Gated on pDC. B. Gated on mDC. Numbers in graph
indicates Median Fluorescent Intensity (MFI). All test conditions were significantly elevated (p,0.05) compared to medium control, except for ICOS-L
for mDC (B). *, p,0.05 for comparison to medium control; #,p ,0.05 for comparison to L. rhamnosus ATCC53103. Representative data from three
independent experiments are shown. Each experiment was done with triplicate cultures; data are mean 6 SD for triplicate cultures.
doi:10.1371/journal.pone.0032588.g001
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L. lactis strains JCM5805, JCM20101 and L. rhamnosus strain
were added to pDC cultures and characterized microscopically. As
shown in Figure 4A, dendrite formation in pDC was elicited by the
L. lactis strains, but not by L. rhamnosus. To test whether there
might be differences between L. lactis and L. rhamnosus in terms of
recognition by pDC, fluorescent dye-labeled LAB strains were
added to pDC, and the efficiency of LAB uptake was assessed. As
shown in Figure 4B, L. lactis strains were incorporated into pDC
within 24 hours, whereas L. rhamnosus was not. L. lactis strains
accumulated cytoplasmically, while L. rhamnosus strain remained
Figure 2. Production of IFNs by Flt-3L induced DC in response
to L. lactis and L. rhamnosus. A. pDC and mDC mixed Flt-3L BM DC
were stimulated with 10 mg/ml of L. lactis JCM5805, JCM20101 and L.
rhamnosus ATCC53103 for 48 hrs. 1 mg/ml of Pam3CSK4 (TLR2L), 5 ng/
ml of LPS (TLR4L), 0.1 mM of CpG-A (TLR9L) were used as positive
controls. Culture supernatants were assayed for IFN-a, IFN-b, IFN-c and
IFN-l by ELISA. B. pDC and mDC mixed Flt-3L BM DC were stimulated
with heat-killed or live JCM5805 strain. 10
6 or 10
8 cells of JCM5805 were
added to culture, respectively. Culture supernatants were assayed for
IFN-a. Representative data from three independent experiments are
shown. Each experiment was done with triplicate cultures; data are
mean 6 SD for triplicate cultures. *, p,0.05 for comparison to medium
control. n.s = no significant difference.
doi:10.1371/journal.pone.0032588.g002
Figure 3. LAB-induced cytokines production in purified pDC,
mDC and mixed cultures. A. pDC and mDC were sorted from Flt-3L
induced BM-derived DC. 10 mg/ml of L. lactis JCM5805, JCM20101 and L.
rhamnosus ATCC53103 were added to pDC, mDC or pDC and mDC
mixed at same ratio (pDC+mDC) for 48 hrs. Concentrations of IFN-a, IL-
12 and TNF-a were determined by ELISA. *, p,0.05 for comparison to
pDC alone (IFN-a) or to mDC alone (IL-12 and TNF-a). B. Effect of
inhibition of direct pDC-mDC contact by transwell system. ‘‘pDC+mDC’’
indicates same number (1610
5 cells each) of pDC and mDC cultured
together. ‘‘pDC/mDC‘‘ indicates pDC and LABs added to the upper
chamber, and mDC added to the lower chamber. ‘‘mDC/pDC’’ indicates
mDC and LABs added to the upper chamber, and pDC added to the
lower chamber. *, p,0.05 for comparison to pDC+mDC. Representative
data from three independent experiments are shown. Each experiment
was done with triplicate cultures; data are mean 6 SD for triplicate
cultures.
doi:10.1371/journal.pone.0032588.g003
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data suggest that the difference in cytokine induction and
morphologic maturation by L. lactis versus L. rhamnosus might
reflect their distinct recognition and compartmentalization by
pDC.
TLR/MyD88 Signaling Responsible for IFN-a Production
Induced by L. Lactis
In order to determine the responsible recognition system leading
to IFN-a induction by L. lactis, Flt-3L DC cultures were evaluated
in selected TLR or MyD88 knockout mouse strains. As shown in
Figure 5, IFN-a production induced by L. lactis strains was
completely abrogated both in TLR9
-/- and MyD88
-/- mice. TLR9
has long been considered as a bacterial sensor based on its
specificity for unmethylated CpG-rich DNA, a characterstic
molecular feature of prokaryotes. Accordingly, DNA was prepared
from LAB strains, and tested for stimulation of IFN-a production
in wild-type Flt-3L DC culture. As shown in Figure 6A, DNA
prepared from L. lactis JCM5805, JCM20101 and L. rhamnosus
ATCC53103 induced significant IFN-a production at 10 mg/ml.
As noted above, L. rhamnosus ATCC53103 did not induce IFN-a
production when added as whole bacteria. However, isolated
DNA from this strain efficiently induced IFN-a, suggesting that L.
rhamnosus ATCC53103 is not recognized by pDC encountered as
whole bacteria. Interestingly, IFN-a production induced by L. lactis
strains was partially decreased in TLR4
-/-, suggesting a contribu-
tion of TLR4L, presumably through recognition of a cell wall
component (Figure 5).
Since complete impairment in TLR9
-/- and partial decrease in
TLR4
-/- were observed, cooperation between TLR4 and TLR9
signaling in IFN-a production was suspected. Therefore, we tested
for a synergistic effect of TLR4L and TLR9L. TLR2Ls, which are
abundant in the Gram-positive bacterial cell wall, were also
examined in combination with the TLR9L CpG ODN. As shown
in Figure 6B, Pam3CSK4, Poly(I:C) and LPS alone could not
induce IFN-a, but a striking elevation of IFN-a was observed
when they were added in combination with CpG ODN compared
to CpG ODN alone. This data suggests that TLR2L, TLR3L or
TLR4L synergistically work with CpG ODN in IFN-a production.
In contrast, the TLR2L, lipoteichoic acid (LTA) decreased IFN-a
production when it was added with CpG-ODN. To further test
this effect, LTA was mixed with LAB-derived DNA, and IFN-a
production was compared with LAB-derived DNA alone. In
accord with CpG ODN, IFN-a production elicited by L. lactis or L.
rhamnosus DNA also was strongly inhibited by lipoteichoic acid
(Figure 6C). This data indicate that different TLR2L compounds
can either promote or inhibit the effect of TLR9L on IFN-a
Figure 4. Morphology of pDC stimulated by LABs and
incorporation into pDC. A. L. lactis JCM5805, JCM20101 and L.
rhamnosus ATCC53103 were added to pDC for 48 hrs, respectively. Cells
were placed onto slide grass by cytospin and stained by Diff-Quick. B.
FITC-stained L. lactis JCM5805, JCM20101 and L. rhamnosus ATCC53103
were added to BM-derived pDC, and were subsequently incubated for
24 hrs. Cells were stained with PE-Cy5.5 labeled anti-B220 antibody as
pDC marker, and imaged by fluorescence microscopy.
doi:10.1371/journal.pone.0032588.g004
Figure 5. Role of TLR signaling in IFN-a production elicited by LAB. Flt-3L induced BM-derived DC were prepared from wild-type (WT), TLR2
-/-
and TLR4
-/- (left panel), or WT, TLR7
-/-, TLR9
-/- and MyD88
-/- (right panel). Cells were cultured in the presence of 0.1 mM of CpG-A or 10 mg/ml of LAB
for subsequent 48 hrs. Representative data from three independent experiments are shown. Each experiment was done with triplicate cultures; data
are mean 6 SD for triplicate cultures. *, p,0.05 for comparison to wild-type.
doi:10.1371/journal.pone.0032588.g005
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be attributable to either contaminating TLRLs sometimes present
in TLR2 preparations; or, distinct co-receptors required by these
two TLR2Ls (lipoteichoic acid, but not Pam3CSK4) requires LBP
and CD14 interaction [43].
Treg Induction by pDC Treated by L. Lactis
ICOS-L and PD-L1 (Figure1A), which were strongly induced
by L. lactis strains, are reported to be involved in Treg
development. Therefore, we tested the effect of L. lactis on the
induction rate of CD4
+CD25
+FoxP3
+ Treg by pDC in the setting
of allogeneic mixed lymphocyte cultures. BM-derived C57BL/
6 pDC were purified and stimulated by L. lactis JCM5805, L.
rhamnosus ATCC53103, or a CpG-ODN positive control. Those
stimulated pDC were then co-cultured with allogenic naı ¨ve
BALB/c CD4
+ T cells, and levels of Treg formation were assessed
(Figure 7). Naı ¨ve CD4
+T cell co-cultured with non-treated pDC
failed to form Treg cells. However, pDC cultured with LAB strains
or CpG were proficient for inducing Treg formation. Moreover, L.
lactis stimulated pDC yielded 1.7-fold higher CD4
+CD25
+FoxP3
+
Treg compared with L. rhamnosus stimulated pDC and similar
tendency was observed by CpG-treated pDC. These findings are
consistent with the prediction that the selective induction of ICOS-
L or PD-L1 by L. lactis (versus L. rhamnosus) may contribute
enhancement of Treg induction by pDC. We also evaluated the
ratio of effector T cells induced by stimulated pDC. IFN-c
producing CD4
+T cells induced by L. lactis stimulated pDC were
similar to CpG-treated pDC, and 1.6-fold increased compared to
L.rhamnosus stimulated pDC.
Effect of Oral Administration of L. Lactis JCM5805 on pDC
in Situ
Since pDC are particularly rare in the intestine, and immature
pDC lack dendrites to incorporate materials from mucosal surface,
it is uncertain if pDC in vivo indeed encounter luminal LAB
resulting from dietary intact. However, enteric bacteria and their
products undergo uptake and transfer to draining mesenteric
lymph nodes (MLN) by several mechanisms. So, we hypothesized
that the response to dietary LAB might be detectable in MLN-
resident pDC. To assess this idea, wild-type C57BL/6 were fed
1 mg/mouse/day of L. lactis JCM5805, and the activation status
(elevated MHC class II and CD86) of DCs were determined after
two-week administration. DCs were evaluated in the spleen
(representative of a negative control, remote systemic lymphoid
site), and the MLN (representing the lymphoid site directly
draining the intestinal tract, where LAB and their products would
accumulate from oral administration). As shown in Figure 8, oral
administration of L. lactis JCM5805 did not effect MHCII and
Figure 6. Effect of LAB-derived nucleic acids and combination
with TLRLs on IFN-a production. A. DNA was extracted from L. lactis
JCM5805, JCM20101 and L. rhamnosus ATCC53103. Each sample was
added at the concentrations of 1, 5, and 10 mg/ml, respectively, to Flt-3L
induced BM-derived DC. B. TLR2Ls (1 mg/ml Pam3CSK4,1 0mg/ml LTA),
TLR3L (10 mg/ml Poly(I:C)) and TLR4L (5 ng/ml LPS) in combination with
0.1 mM of CpG-A and IFN-a production were measured. *, p,0.05 for
comparison to CpG-A alone. C. Effect of LTA on IFN-a production
induced by LAB-derived DNA. 10 mg/ml of LTA was mixed with 10 mg/
ml of DNA prepared from L. lactis JCM5805, JCM20101 or L. rhamnosus
ATCC53103 and added to Flt-3L induced BM-derived DC. *, p,0.05 for
comparison to LAB-derived DNA alone. Representative data from three
independent experiments are shown. Each experiment was done with
triplicate cultures; data are mean 6 SD for triplicate cultures.
doi:10.1371/journal.pone.0032588.g006
Figure 7. CD4
+CD25
+FoxP3
+Treg and IFN-c producing CD4
+T
cell generation by L. lactis JCM5805-treated pDC. MLR reactions
using naı ¨ve CD4
+T cell prepared from BALB/c and purified C57BL/6
derived-pDC stimulated by L. lactis JCM5805 (10 mg/ml) or L. rhamnosus
ATCC53103 (10 mg/ml) or CpG-A (0.1 mM) was performed. After 7 days,
cells were collected and stained for induced Treg cells (Data was gated
for CD3
+CD4
+ cells, and graphed for CD25 and FoxP3 expression) or
IFN-c producing CD4
+?T cells (Data was gated for CD3
+ cells, and
graphed for CD4 and IFN-c expression). A representative dataset from
three independent experiments with singlet culture is shown.
doi:10.1371/journal.pone.0032588.g007
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but statistically significant increase of MHCII and CD86 were
observed on pDC located in the MLN. Regarding mDC,
JCM5805 induced an increase in CD86 both spleen and MLN
derived from JCM5805 group; curiously, this was not accompa-
nied by any change in MHCII expression. These data suggest that
small amounts of L. lactis JCM5805 administrated orally might be
taken up from the intestinal tract, and indeed activate pDC at
draining mucosal sites.
Discussion
The present study is the first demonstration that certain LAB
strains commonly used in food products directly stimulate pDC to
produce type I and type III IFN. It was intriguing that only select
spherical LAB strains stimulated IFN-a production. This was
analyzed in detail with strains of L. lactis versus the bacillary
species, L. rhamnosus, raising the simple possibility that pDC may
sense size or shape of bacteria. Most studies of bacterial IFN
induction in DC involve pathogenic intracellular and extracellular
bacteria, and such induction was not observed in the pDC subset,
perhaps due to their deficiency in bacterial uptake [44]. Among
bacterial pathogens, the spherical bacterium S. aureus was shown to
activate pDC directly [27]. In the case of Helicobacter pylori, a
change in its morphology from spiral-shaped into coccoid formis
was observed upon phagocytosis by resident dendritic cells located
in Peyer’s patch [45]. However, since only select spherical
bacterial species induce pDC activation, other factors besides
morphology are obviously involved. In a series of knockout mouse
experiments, we demonstrated that L. lactis stimulation of pDC
IFN-a production involved a key role for TLR9 in the context of
MyD88 signaling, and a complementary role for TLR2 or TLR4
sensing. In this respect, the stimulatory LAB strains might be
considered an immunomodulatory ‘‘drug-delivery system’’, with
an interior TLR9 ligand and ‘‘outer envelope’’ bearing TLR2 or
TLR4 ligands.
The synergism of mDC interaction on pDC IFN-a production
was intriguing. Most LAB strains stimulate NK cell, macrophage
and mDC function, hence affecting diverse cytokines and cell-
surface molecules which affect IFN-a. For example, CD40 and
IFN-c synergistically increase IFN-a production [46]. IFN-c is a
typical cytokine increased by LAB administration, due to its direct,
strong induction of IL-12, leading to IFN-c by Th1 and NK cells
[28,29,32]. CD40 is a commonly induced receptor in activated
mDC and macrophages, and is up-regulated by LAB [32].
Interaction between CD40 on conventional DC and CD40 ligand
on pDC can lead to IL-12 production by mDC [47], and such
crosstalk may partly explain the synergy of mDC coculture for
pDC production of IFN-a.
A number of studies have mentioned the effect of LAB strains
on immune activation including IFN-a production. Kitazawa et al.
showed that Lactobacillus strains induce IFN-a from macrophages
[48], and Izumo et al. observed that intranasal or oral
administration of L. pentosus strain resulted in enhancement of
IFN-a production elicited by viral infection, a response in part
attributable to the pDC subpopulation [49,50]. In present study,
we have shown that L. lactis strains are able to induce not only type
I IFN but also IFN-l. IFN-l is known to induce identical signal
transduction to type I IFN, although its role is critical especially in
the mucosal site because its receptor is preferentially expressed on
epithelial cells [51]. Therefore, administration of those LAB strains
might be effective not only systemic infectious virus but also
intestinal viral infection such as rotavirus.
The in vivo compartment for encounter of pDC with dietary
LAB or their products is uncertain. pDC are quite rare in the
intestine itself, where they also lack dendrites, and in their
quiescent state, show poor phagocytosis of foreign antigens. We
therefore hypothesized that LAB or their products, like enteric
commensal microbiota, might undergo intestinal uptake and
transfer to the directly draining MLN, where resident pDC would
undergo LAB encounter. When it was administrated orally for two
weeks to healthy mice using JCM5805 as a representative of pDC-
stimulatory strain, activation markers were modestly but signifi-
cantly elevated in pDC resident in MLNs. In contrast, no such
activation was seen in pDC resident in a remote lymphoid site
(spleen). Curiously, a distinct mode of mDC activation was
observed resident in both draining and remote lymphoid sites.
These observations support our hypothesis, although more work
Figure 8. Effect of oral administration of L. lactis JCM5805 to healthy C57BL/6 mice. Healthy C57BL/6 mice were divided into two groups
(n=8 each). Control group (ctrl) were fed a normal diet, and L. lactis group (JCM5805) were fed a diet containing 1 mg of JCM5805 per day. Two
weeks later, low density cells fractions prepared from SPN (A) or MLN (B) derived each group were analyzed for MHCII and CD86 on pDC or mDC.
Representative data from three independent experiments are shown.
doi:10.1371/journal.pone.0032588.g008
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lumen, and the lymphoid sites and DC subsets responding to oral
LAB in vivo.
The pDC population has diverse immunomodulatory roles,
ranging from the enhancement of anti-viral immunity (notably
through IFN-a production) to augmentation of differentiation of
CD4
+ induced Treg cells [40,41]. Paradoxically, IFN-a itself
interferes with survival of immunoregulatory CD4
+CD25
+Treg
[52], and in vivo, promotes autoimmune and chronic inflammatory
diseases[53].However,thepresentstudyrevealedthatstimulationof
pDCwithIFN-ainducingL.lactisaugmentedthecapacityofpDCto
induce CD4
+CD25
+Treg generation. This may in part reflect the
capacity of these L. lactis strains to up-regulate pDC expression of
ICOS-L and PD1-L, which are important for Treg generation
[41,42]. Conversely, L. lactis treated pDC also induce Th1
differentiation, at levels comparable to CpG-treated pDC [54]. It is
thus possible that the immunomodulatory effects of L. lactis on pDC
may involveoverlapping mechanisms withCpG. Thus,itis possible
that L. lactis stimulation of pDC results in an integrated immuno-
modulatoryresponsethatmaybothaugmentanti-viralimmunityand
attenuate chronic inflammatory states that may be beneficial for
promoting tissue repair after infection-mediated injury.
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